Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson's disease using electropalatography: A pilot study

Clinical Linguistics and Phonetics

Volumn 25, Issue 3, 2011, Pages 210-230

  Hartinger, Mariam ^a   Tripoliti, Elina ^b   Hardcastle, William J ^a   Limousin, Patricia ^b  

^a QUEEN MARGARET UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

deep brain stimulation; dysarthria; electropalatography; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT;

ANALYSIS OF VARIANCE; ARTICLE; BRAIN DEPTH STIMULATION; COMPARATIVE STUDY; DRUG EFFECT; ELECTRODIAGNOSIS; HUMAN; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); PARKINSON DISEASE; PATHOPHYSIOLOGY; PILOT STUDY; SPEECH; SPEECH ANALYSIS; SUBTHALAMIC NUCLEUS; TIME; TONGUE;

ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; ELECTRODIAGNOSIS; HUMANS; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; PILOT PROJECTS; SPEECH; SPEECH PRODUCTION MEASUREMENT; SUBTHALAMIC NUCLEUS; TIME FACTORS; TONGUE;

EID: 79951594306     PISSN: 02699206     EISSN: 14645076     Source Type: Journal    
DOI: 10.3109/02699206.2010.521877     Document Type: Article

References (45)

1. Ackermann, H., Konczak J., & Hertrich, I. (1997). The temporal control of repetitive articulatory movements in Parkinsons disease. Brain and Language, 56, 312-319. (Pubitemid 27184985)
2. Byrd, D., Flemming, E., Mueller, C. A., & Tan, C. C. (1995). Using regions and indices in EPG data reduction. Journal of Speech and Hearing Research, 38, 821-827.
3. DAlatri, L., Paludetti, G., Contarino, F. M., Galla, S., Marchese, M. R., & Bentivoglio, A. R. (2008). Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment. Journal of Voice, 22, 365-372. (Pubitemid 351609321)
4. Darley, F. L., Aronson, A. E., & Brown, J. R. (1975). Motor speech disorders. Philadelphia PA: W.B. Saunders Company.
5. De Letter, M., Santens, P., De Bodt, M., Boon, P., & Van Borsel, J. (2006). Levodopa-induced alterations in speech rate in advanced Parkinsons disease. Acta Neurologica Belgica, 106, 19-22. (Pubitemid 43805090)
6. De Letter, M., Santens, P., De Bodt, M., Van Maele, G., Van Borsel, J., & Boon, P. (2007). The effect of levodopa on respiration and word intelligibility in people with advanced Parkinsons disease. Clinical Neurology and Neurosurgery, 109, 495-500. (Pubitemid 46783198)
7. De Letter, M., Santens, P., & Van Borsel, J. (2005). The effects of levodopa on word intelligibility in Parkinsons disease. Journal of Communication Disorders, 38, 187-196. (Pubitemid 40312802)
8. Deuschl, G., Herzog, J., Kleiner-Fisman, G., Kubu, C., Lozano, A. M., Lyons, K. E., Rodriguez-Oroz, M. C., Tamma, F., Troster, A. I., Vitek, J. L., Volkmann, J., & Voon, V. (2006). Deep brain stimulation: postoperative issues. Movement Disorders, 21 (Suppl 14), S219-S237. (Pubitemid 44028283)
9. Fahn, S., & Elton R. L. (1987). UPDRS program members. Unified Parkinsons disease rating scale. In S. Fahn, C. D. Marsden, M. Goldstein, & D. B. Calne (Eds.), Recent developments in Parkinsons disease (pp. 153-163, 293- 304). Florham Park, NJ: Macmillan Healthcare Information.
10. Farrell, A., Theodoros, D., Ward, E., Hall, B., & Silburn, P. (2005). Effects of neurosurgical management of Parkinsons disease on speech characteristics and oromotor function. Journal of Speech, Language, and Hearing Research, 48, 5-20. (Pubitemid 40470870)
11. Gentil, M., Chauvin, P., Pinto, S., Pollak, P., & Benabid, A. L. (2001). Effect of bilateral stimulation of the subthalamic nucleus on Parkinsonian voice. Brain and Language, 78, 233-240. (Pubitemid 32758107)
12. Gentil, M., Garcia-Ruiz, P., Pollak, P., & Benabid, A. L. (1999). Effect of stimulation of the subthalamic nucleus on oral control of patients with Parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry, 67, 329-333. (Pubitemid 29392592)
13. Gentil, M., Pinto, S., Pollak, P.,&Benabid, A. L. (2003). Effect of bilateral stimulation of the subthalamic nucleus on Parkinsonian dysarthria. Brain and Language, 85, 190-196. (Pubitemid 36542853)
14. Goberman, A.M., & Blomgren, M. (2003). Parkinsonian speech disfluencies: effects of L-dopa-related fluctuations. Journal of Fluency Disorders, 28, 55-70. (Pubitemid 36438619)
15. Goberman, A. M., & Blomgren, M. (2008). Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease. Journal of Voice, 22, 178-191. (Pubitemid 351273975)
16. Goberman, A.M., & Coelho, C. (2002). Acoustic analysis of Parkinsonian speech II: L-dopa related fluctuations and methodological issues. NeuroRehabilitation, 17, 247-254. (Pubitemid 35025013)
17. Gurd, J. M., Bessell, N., Watson, I., & Coleman, J. (1998). Motor speech versus digit control in Parkinsons disease: a cognitive neuropsychology investigation. Clinical Linguistics and Phonetics, 12, 357-378. (Pubitemid 28288625)
18. Hardcastle, W. J., Morgan Barry, R. A., & Clark, C. J. (1985). Articulatory and voicing characteristics of adult dysarthric and verbal dyspraxic speakers: an instrumental study. British Journal of Disorders of Communication, 20, 249-270. (Pubitemid 16224581)
19. Hariz, M. I., Johansson, F., Shamsgovara, P., Johansson, E., Hariz, G. M., & Fagerlund, M. (2000). Bilateral subthalamic nucleus stimulation in a Parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Movement Disorders, 15, 136-139. (Pubitemid 30037999)
20. Kent, R. D., & Kim, Y. J. (2003). Toward an acoustic typology of motor speech disorders. Clinical Linguistics and Phonetics, 17, 427-445. (Pubitemid 37258368)
21. Kent, R. D., Weismer, G., Kent, J. F., & Rosenbek, J. C. (1989). Toward phonetic intelligibilty testing in dysathria. Journal of Speech and Hearing Disorders, 54, 482-499. (Pubitemid 19274774)
22. Kleiner-Fisman, G., Fisman, D. N., Zamir, O., Dostrovsky, J. O., Sime, E., Saint-Cyr, J. A., Lozano, A. M., & Lang, A. E. (2004). Subthalamic nucleus deep brain stimulation for Parkinsons disease after successful pallidotomy: clinical and electrophysiological observations. Movement Disorders, 19, 1209-1214. (Pubitemid 39429964)
23. Klostermann, F., Ehlen, F., Vesper, J., Nubel, K., Gross, M.,Manzinzik, F., Curio, G., & Sappok, T. (2008). Effects of subthalamic nucleus deep brain stimulation on dysarthrophonia in Parkinsons disease. Journal of Neurology, Neurosurgery and Psychiatry, 79, 522-529. (Pubitemid 351571869)
24. Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., Benabid, A. L., & Pollak, P. (2003). Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinsons disease. New England Journal of Medicine, 349, 1925-1934. (Pubitemid 37409709)
25. Levelt, W. J. M. (1989). Speaking: from intention to articulation. Cambridge, MA: MIT Press.
26. Limousin, P., Krack, P., Pollak, P., Benazzouz, ., Ardouin, C., Hoffmann, D., & Benabid, A. L. (1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinsons disease. New England Journal of Medicine, 339, 1105-1111. (Pubitemid 28465758)
27. Logemann, J. A., & Fisher, H. B. (1981). Vocal tract control in Parkinsons disease. Journal of Speech and Hearing Disorders, 46, 348-352.
28. Logemann, J. A., Fisher, H. B., Boshes, B., & Blonsky, E. R. (1978). Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech and HearingDisorders, 43, 47-57. (Pubitemid 8282392)
29. Ludlow, C. L., Connor, N. P., & Bassich, C. L. (1987). Speech timing in Parkinsons and Huntingtons disease. Brain and Language, 32, 195-214. (Pubitemid 18000837)
30. McAuliffe, M. J., Ward, E. C., & Murdoch, B. E. (2006a). Speech production in Parkinsons disease: I. An electropalatographic investiation of tongue-palate contact patterns. Clinical Linguistics and Phonetics, 20, 1-18. (Pubitemid 43102015)
31. McAuliffe, M. J., Ward, E. C., & Murdoch, B. E. (2006b). Speech production in Parkinsons disease: II. Acoustic and electropalatographic investiation of sentence, word and segment durations. Clinical Linguistics and Phonetics, 20, 19-33. (Pubitemid 43102016)
32. McAuliffe, M. J., Ward, E. C., & Murdoch, B. E. (2007). Intra-participant variability in Parkinsons disease: an electropalatographic examination of articulation. Advances in Speech-Language Pathology, 9, 13-19.
33. Metter, E. J., & Hanson, W. R. (1986). Clinical and acoustical variability in hypokinetic dysarthria. Journal of Communication Disorders, 19, 347-366.
34. Nakano, K. K., Zubick, H., & Tyler, H. R. (1973). Speech defects of Parkinsonian patients: effects of levodopa therapy on speech intelligibilty. Neurology, 23, 865-870.
35. Pinto, S., Fillatra, G., & Ghio, A. (2009). Functional neuroimaging of speech production in Parkinsons disease: towards a better understanding of dysarthria physiopathology. In S. Fuchs (Ed.), Some aspects of speech and the brain (pp. 115-140). Frankfurt am Main: Peter Lang.
36. Pinto, S., Gentil, M., Fraix, V., Benabid, A. L., & Pollak, P. (2003). Bilateral subthalamic stimulation effects on oral force control in Parkinsons disease. Journal of Neurology, 250, 179-287.
37. Pinto, S., Gentil, M., Krack, P., Sauleau, P., Fraix, V., Benabid, A. L., & Pollak, P. (2005). Changes induced by levodopa and subthalamic nucleus stimulation on Parkinsonian speech. Movement Disorders, 20, 1507-1515. (Pubitemid 43072662)
38. Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-Dowsey, P., & Auzou, P. (2004). Treatments for dysarthria in Parkinsons disease. Lancet Neurology, 3, 547-556.
39. Pützer, M., Barry, W. J., & Moringlane, J. R. (2008). Effect of bilateral stimulation of the subthalamic nucleus on different speech subsystems in patients with Parkinsons disease. Clinical Linguistics and Phonetics, 22, 957-973.
40. Rosen, K. M., Kent, R. D., & Duffy, J. R. (2005). Task-based profile of vocal intensity decline in Parkinsons disease. Folia Phoniatrica et Logopaedica, 57, 28-37.
41. Rousseaux, M., Krystkowiak, P., Kozlowski, O., Özsancak, C., Blond, S., & Destée, A. (2004). Effets of subthalamic nucleus stimulation on Parkinsonian dysarthria and speech intelligibility. Journal of Neurology, 327-334. (Pubitemid 38387152)
42. Schirmer,A. (2004).Timing speech: a reviewof lesion and neuroimaging findings. CognitiveBrain Research, 21, 269-287. (Pubitemid 39298929)
43. Schulz, G. M., & Grant, M. K. (2000). Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinsons disease: a review of the literature. Journal of Communication Disorders, 33, 59-88. (Pubitemid 30067615)
44. Weismer, G. (1984). Articulatory characteristics of Parkinsonian dysarthria: segmental and phrase-level timing, spirantization, and glottal-supraglottal coordination. In M. McNeil, J. Rosenbek, & A. Aronson (Eds.), The dysarthrias: Psychology, acoustics, perception, management (pp. 101-130). San Diego, CA: College-Hill Press.
45. Yorkston, K., & Beukelman, D. (1984). Assessment of intelligibility of dysarthric speech. Austin: Pro-ed.